The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Edaravone API Market Research Report 2024
Synopsis
Edaravone is a free radical scavenger approved in May, 2017 for the treatment of amyotrophic lateral scleorosis (ALS). Clinical studies showed that the treatment attenuated deterioration of the disease when compared to placebo. It has been previously investigated for the treatment of ischemic stroke, reperfusion Injury, and myocardial Infarction as it possesses antioxidant and anti-apoptotic properties. Being a low molecular weight molecule with good water and lipid-soluble properies, it is therapeutically advantageous in crossing the blood-brain barrier to mediate nootropic and neuroprotective effects. Oral formulation of edaravone is currently under development.
The global Edaravone API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Edaravone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Edaravone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Edaravone API include Dr. Reddy’s Laboratories Ltd., ChemWerth Inc, Medichem S.A, Solara Active Pharma Sciences, Neuland Laboratories and Jiangsu Haici Bio-Pharmaceutical Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Edaravone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone API.
Report Scope
The Edaravone API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edaravone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edaravone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s Laboratories Ltd.
ChemWerth Inc
Medichem S.A
Solara Active Pharma Sciences
Neuland Laboratories
Jiangsu Haici Bio-Pharmaceutical Co., Ltd
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Edaravone Injection
Others
Production by Region
North America
Europe
China
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Edaravone API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Edaravone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Edaravone is a free radical scavenger approved in May, 2017 for the treatment of amyotrophic lateral scleorosis (ALS). Clinical studies showed that the treatment attenuated deterioration of the disease when compared to placebo. It has been previously investigated for the treatment of ischemic stroke, reperfusion Injury, and myocardial Infarction as it possesses antioxidant and anti-apoptotic properties. Being a low molecular weight molecule with good water and lipid-soluble properies, it is therapeutically advantageous in crossing the blood-brain barrier to mediate nootropic and neuroprotective effects. Oral formulation of edaravone is currently under development.
The global Edaravone API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Edaravone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Edaravone API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Edaravone API include Dr. Reddy’s Laboratories Ltd., ChemWerth Inc, Medichem S.A, Solara Active Pharma Sciences, Neuland Laboratories and Jiangsu Haici Bio-Pharmaceutical Co., Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Edaravone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone API.
Report Scope
The Edaravone API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edaravone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edaravone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s Laboratories Ltd.
ChemWerth Inc
Medichem S.A
Solara Active Pharma Sciences
Neuland Laboratories
Jiangsu Haici Bio-Pharmaceutical Co., Ltd
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Edaravone Injection
Others
Production by Region
North America
Europe
China
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Edaravone API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Edaravone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Edaravone API Market Overview
1.1 Product Definition
1.2 Edaravone API Segment by Type
1.2.1 Global Edaravone API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Edaravone API Segment by Application
1.3.1 Global Edaravone API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Edaravone Injection
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Edaravone API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Edaravone API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Edaravone API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Edaravone API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Edaravone API Production Market Share by Manufacturers (2019-2024)
2.2 Global Edaravone API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Edaravone API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Edaravone API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Edaravone API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Edaravone API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Edaravone API, Product Offered and Application
2.8 Global Key Manufacturers of Edaravone API, Date of Enter into This Industry
2.9 Edaravone API Market Competitive Situation and Trends
2.9.1 Edaravone API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Edaravone API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Edaravone API Production by Region
3.1 Global Edaravone API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Edaravone API Production Value by Region (2019-2030)
3.2.1 Global Edaravone API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Edaravone API by Region (2025-2030)
3.3 Global Edaravone API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Edaravone API Production by Region (2019-2030)
3.4.1 Global Edaravone API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Edaravone API by Region (2025-2030)
3.5 Global Edaravone API Market Price Analysis by Region (2019-2024)
3.6 Global Edaravone API Production and Value, Year-over-Year Growth
3.6.1 North America Edaravone API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Edaravone API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Edaravone API Production Value Estimates and Forecasts (2019-2030)
3.6.4 India Edaravone API Production Value Estimates and Forecasts (2019-2030)
4 Edaravone API Consumption by Region
4.1 Global Edaravone API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Edaravone API Consumption by Region (2019-2030)
4.2.1 Global Edaravone API Consumption by Region (2019-2024)
4.2.2 Global Edaravone API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Edaravone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Edaravone API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Edaravone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Edaravone API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Edaravone API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Edaravone API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Edaravone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Edaravone API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Edaravone API Production by Type (2019-2030)
5.1.1 Global Edaravone API Production by Type (2019-2024)
5.1.2 Global Edaravone API Production by Type (2025-2030)
5.1.3 Global Edaravone API Production Market Share by Type (2019-2030)
5.2 Global Edaravone API Production Value by Type (2019-2030)
5.2.1 Global Edaravone API Production Value by Type (2019-2024)
5.2.2 Global Edaravone API Production Value by Type (2025-2030)
5.2.3 Global Edaravone API Production Value Market Share by Type (2019-2030)
5.3 Global Edaravone API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Edaravone API Production by Application (2019-2030)
6.1.1 Global Edaravone API Production by Application (2019-2024)
6.1.2 Global Edaravone API Production by Application (2025-2030)
6.1.3 Global Edaravone API Production Market Share by Application (2019-2030)
6.2 Global Edaravone API Production Value by Application (2019-2030)
6.2.1 Global Edaravone API Production Value by Application (2019-2024)
6.2.2 Global Edaravone API Production Value by Application (2025-2030)
6.2.3 Global Edaravone API Production Value Market Share by Application (2019-2030)
6.3 Global Edaravone API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Edaravone API Corporation Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Edaravone API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Edaravone API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 ChemWerth Inc
7.2.1 ChemWerth Inc Edaravone API Corporation Information
7.2.2 ChemWerth Inc Edaravone API Product Portfolio
7.2.3 ChemWerth Inc Edaravone API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 ChemWerth Inc Main Business and Markets Served
7.2.5 ChemWerth Inc Recent Developments/Updates
7.3 Medichem S.A
7.3.1 Medichem S.A Edaravone API Corporation Information
7.3.2 Medichem S.A Edaravone API Product Portfolio
7.3.3 Medichem S.A Edaravone API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Medichem S.A Main Business and Markets Served
7.3.5 Medichem S.A Recent Developments/Updates
7.4 Solara Active Pharma Sciences
7.4.1 Solara Active Pharma Sciences Edaravone API Corporation Information
7.4.2 Solara Active Pharma Sciences Edaravone API Product Portfolio
7.4.3 Solara Active Pharma Sciences Edaravone API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Solara Active Pharma Sciences Main Business and Markets Served
7.4.5 Solara Active Pharma Sciences Recent Developments/Updates
7.5 Neuland Laboratories
7.5.1 Neuland Laboratories Edaravone API Corporation Information
7.5.2 Neuland Laboratories Edaravone API Product Portfolio
7.5.3 Neuland Laboratories Edaravone API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Neuland Laboratories Main Business and Markets Served
7.5.5 Neuland Laboratories Recent Developments/Updates
7.6 Jiangsu Haici Bio-Pharmaceutical Co., Ltd
7.6.1 Jiangsu Haici Bio-Pharmaceutical Co., Ltd Edaravone API Corporation Information
7.6.2 Jiangsu Haici Bio-Pharmaceutical Co., Ltd Edaravone API Product Portfolio
7.6.3 Jiangsu Haici Bio-Pharmaceutical Co., Ltd Edaravone API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Jiangsu Haici Bio-Pharmaceutical Co., Ltd Main Business and Markets Served
7.6.5 Jiangsu Haici Bio-Pharmaceutical Co., Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Edaravone API Industry Chain Analysis
8.2 Edaravone API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Edaravone API Production Mode & Process
8.4 Edaravone API Sales and Marketing
8.4.1 Edaravone API Sales Channels
8.4.2 Edaravone API Distributors
8.5 Edaravone API Customers
9 Edaravone API Market Dynamics
9.1 Edaravone API Industry Trends
9.2 Edaravone API Market Drivers
9.3 Edaravone API Market Challenges
9.4 Edaravone API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Edaravone API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Edaravone API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Edaravone API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Edaravone API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Edaravone API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Edaravone API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Edaravone API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Edaravone API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Edaravone API as of 2023)
Table 10. Global Market Edaravone API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Edaravone API Production Sites and Area Served
Table 12. Manufacturers Edaravone API Product Types
Table 13. Global Edaravone API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Edaravone API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Edaravone API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Edaravone API Production Value Market Share by Region (2019-2024)
Table 18. Global Edaravone API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Edaravone API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Edaravone API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Edaravone API Production (Ton) by Region (2019-2024)
Table 22. Global Edaravone API Production Market Share by Region (2019-2024)
Table 23. Global Edaravone API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Edaravone API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Edaravone API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Edaravone API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Edaravone API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Edaravone API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Edaravone API Consumption Market Share by Region (2019-2024)
Table 30. Global Edaravone API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Edaravone API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Edaravone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Edaravone API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Edaravone API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Edaravone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Edaravone API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Edaravone API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Edaravone API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Edaravone API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Edaravone API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Edaravone API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Edaravone API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Edaravone API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Edaravone API Production (Ton) by Type (2019-2024)
Table 45. Global Edaravone API Production (Ton) by Type (2025-2030)
Table 46. Global Edaravone API Production Market Share by Type (2019-2024)
Table 47. Global Edaravone API Production Market Share by Type (2025-2030)
Table 48. Global Edaravone API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Edaravone API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Edaravone API Production Value Share by Type (2019-2024)
Table 51. Global Edaravone API Production Value Share by Type (2025-2030)
Table 52. Global Edaravone API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Edaravone API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Edaravone API Production (Ton) by Application (2019-2024)
Table 55. Global Edaravone API Production (Ton) by Application (2025-2030)
Table 56. Global Edaravone API Production Market Share by Application (2019-2024)
Table 57. Global Edaravone API Production Market Share by Application (2025-2030)
Table 58. Global Edaravone API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Edaravone API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Edaravone API Production Value Share by Application (2019-2024)
Table 61. Global Edaravone API Production Value Share by Application (2025-2030)
Table 62. Global Edaravone API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Edaravone API Price (US$/Ton) by Application (2025-2030)
Table 64. Dr. Reddy’s Laboratories Ltd. Edaravone API Corporation Information
Table 65. Dr. Reddy’s Laboratories Ltd. Specification and Application
Table 66. Dr. Reddy’s Laboratories Ltd. Edaravone API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
Table 68. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
Table 69. ChemWerth Inc Edaravone API Corporation Information
Table 70. ChemWerth Inc Specification and Application
Table 71. ChemWerth Inc Edaravone API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. ChemWerth Inc Main Business and Markets Served
Table 73. ChemWerth Inc Recent Developments/Updates
Table 74. Medichem S.A Edaravone API Corporation Information
Table 75. Medichem S.A Specification and Application
Table 76. Medichem S.A Edaravone API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Medichem S.A Main Business and Markets Served
Table 78. Medichem S.A Recent Developments/Updates
Table 79. Solara Active Pharma Sciences Edaravone API Corporation Information
Table 80. Solara Active Pharma Sciences Specification and Application
Table 81. Solara Active Pharma Sciences Edaravone API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Solara Active Pharma Sciences Main Business and Markets Served
Table 83. Solara Active Pharma Sciences Recent Developments/Updates
Table 84. Neuland Laboratories Edaravone API Corporation Information
Table 85. Neuland Laboratories Specification and Application
Table 86. Neuland Laboratories Edaravone API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Neuland Laboratories Main Business and Markets Served
Table 88. Neuland Laboratories Recent Developments/Updates
Table 89. Jiangsu Haici Bio-Pharmaceutical Co., Ltd Edaravone API Corporation Information
Table 90. Jiangsu Haici Bio-Pharmaceutical Co., Ltd Specification and Application
Table 91. Jiangsu Haici Bio-Pharmaceutical Co., Ltd Edaravone API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Jiangsu Haici Bio-Pharmaceutical Co., Ltd Main Business and Markets Served
Table 93. Jiangsu Haici Bio-Pharmaceutical Co., Ltd Recent Developments/Updates
Table 94. Key Raw Materials Lists
Table 95. Raw Materials Key Suppliers Lists
Table 96. Edaravone API Distributors List
Table 97. Edaravone API Customers List
Table 98. Edaravone API Market Trends
Table 99. Edaravone API Market Drivers
Table 100. Edaravone API Market Challenges
Table 101. Edaravone API Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Edaravone API
Figure 2. Global Edaravone API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Edaravone API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Edaravone API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Edaravone API Market Share by Application: 2023 VS 2030
Figure 8. Edaravone Injection
Figure 9. Others
Figure 10. Global Edaravone API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Edaravone API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Edaravone API Production Capacity (Ton) & (2019-2030)
Figure 13. Global Edaravone API Production (Ton) & (2019-2030)
Figure 14. Global Edaravone API Average Price (US$/Ton) & (2019-2030)
Figure 15. Edaravone API Report Years Considered
Figure 16. Edaravone API Production Share by Manufacturers in 2023
Figure 17. Edaravone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Edaravone API Revenue in 2023
Figure 19. Global Edaravone API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Edaravone API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Edaravone API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 22. Global Edaravone API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Edaravone API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Edaravone API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Edaravone API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. India Edaravone API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Edaravone API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 28. Global Edaravone API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 30. North America Edaravone API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. U.S. Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. Europe Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 34. Europe Edaravone API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. France Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. U.K. Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. Italy Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. Russia Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Asia Pacific Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 41. Asia Pacific Edaravone API Consumption Market Share by Regions (2019-2030)
Figure 42. China Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. Japan Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. South Korea Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. China Taiwan Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. Southeast Asia Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. India Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Latin America, Middle East & Africa Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 49. Latin America, Middle East & Africa Edaravone API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Brazil Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. Turkey Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. GCC Countries Edaravone API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 54. Global Production Market Share of Edaravone API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Edaravone API by Type (2019-2030)
Figure 56. Global Edaravone API Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Edaravone API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Edaravone API by Application (2019-2030)
Figure 59. Global Edaravone API Price (US$/Ton) by Application (2019-2030)
Figure 60. Edaravone API Value Chain
Figure 61. Edaravone API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
